Director/PDMR Shareholding

14 July 2011

Synergy Health plc ("Synergy" or the "Company")

Director/PDMR Shareholding

The Company was notified that on 11 July 2011 Marcello Smit, Synergy's CEO Europe and Middle East, purchased 7,000 ordinary shares of 0.625p each in the Company ("Ordinary Shares") at a price of 923.00 pence per share, and has allocated these shares to the LTIP Co-Invest scheme. As such, Marcello Smit has been awarded 14,000 LTIP Co-Invest options. Following this transaction, Mr. Smit has an interest in 35,988 Ordinary Shares, representing 0.07% of the Company's issued share capital.

The LTIP Co-Invest arrangement requires that the participant to whom the award is to be made invests in Ordinary Shares in the Company and continues to hold those Ordinary Shares throughout the three year measurement period. At the end of the measurement period, depending upon the growth in earnings per share of the Company over the measurement period, the participant will receive a number of "matching" shares at nominal value under the LTIP Co-Invest

Enquiries

Tim Mason

Company Secretary

01793 891862